Perspective Therapeutics, Inc. · AMEX:CATX
Morgan Stanley's stake in Perspective Therapeutics, Inc. fell to 2.60% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 12, 2026
Morgan Stanley's stake in Perspective Therapeutics, Inc. fell to 2.60%, 2,959,296 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G/A).
- Stake
- 2.60%
- Shares
- 2,959,296
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 2.60% | 2,959,296 |
Source
Related
- Perspective Therapeutics, Inc.
- Morgan Stanley
- Perspective Therapeutics, Inc. shareholders
- Schedule 13G · Morgan Stanley · Feb 12, 2026
- Schedule 13D/A · Lantheus Holdings, Inc. · Sep 23, 2026
- Form 4 · Lantheus Alpha Therapy, LLC · Sep 8, 2026
- Form 4 · Lantheus Holdings, Inc. · Sep 4, 2026
- Form 4 · Lantheus Alpha Therapy, LLC · Sep 4, 2026
- Schedule 13D/A · Lantheus Holdings, Inc. · Sep 4, 2026